Works by Nakazato, Kenji

Results: 5
    1

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    2
    3

    Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 3, p. 201, doi. 10.1159/000540841
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    4

    ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study.

    Published in:
    2024
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Abstract
    5

    Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 13, p. 9023, doi. 10.1245/s10434-024-16161-4
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article